Connor Clark & Lunn Investment Management Ltd. grew its stake in eHealth, Inc. (NASDAQ:EHTH - Free Report) by 163.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 177,012 shares of the financial services provider's stock after buying an additional 109,814 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned 0.60% of eHealth worth $1,664,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of EHTH. R Squared Ltd purchased a new position in shares of eHealth in the 4th quarter valued at about $29,000. Public Employees Retirement System of Ohio increased its stake in shares of eHealth by 40.7% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 12,451 shares of the financial services provider's stock valued at $51,000 after purchasing an additional 3,600 shares in the last quarter. SkyView Investment Advisors LLC increased its stake in shares of eHealth by 28.7% in the 3rd quarter. SkyView Investment Advisors LLC now owns 30,000 shares of the financial services provider's stock valued at $122,000 after purchasing an additional 6,694 shares in the last quarter. Barclays PLC increased its stake in shares of eHealth by 104.3% in the 3rd quarter. Barclays PLC now owns 47,445 shares of the financial services provider's stock valued at $194,000 after purchasing an additional 24,224 shares in the last quarter. Finally, Kera Capital Partners Inc. purchased a new position in shares of eHealth in the 4th quarter valued at about $358,000. Institutional investors and hedge funds own 79.54% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have commented on EHTH shares. StockNews.com upgraded eHealth from a "sell" rating to a "hold" rating in a research note on Friday, March 7th. Royal Bank of Canada cut their price objective on eHealth from $13.00 to $11.00 and set a "sector perform" rating for the company in a research note on Monday, November 25th. Finally, UBS Group started coverage on eHealth in a research note on Wednesday, December 4th. They set a "neutral" rating and a $5.50 price objective for the company. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $6.38.
View Our Latest Analysis on EHTH
eHealth Price Performance
Shares of EHTH stock traded down $0.23 during trading hours on Friday, reaching $7.17. The company had a trading volume of 236,945 shares, compared to its average volume of 254,361. The company has a debt-to-equity ratio of 0.14, a quick ratio of 3.10 and a current ratio of 3.10. The stock has a fifty day moving average of $9.33 and a 200-day moving average of $6.91. The company has a market capitalization of $214.69 million, a price-to-earnings ratio of -2.52 and a beta of 0.44. eHealth, Inc. has a 12-month low of $3.58 and a 12-month high of $11.36.
eHealth (NASDAQ:EHTH - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The financial services provider reported $2.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.00 by $0.20. eHealth had a negative return on equity of 5.70% and a negative net margin of 7.58%. The business had revenue of $315.18 million during the quarter, compared to analyst estimates of $293.47 million. On average, equities analysts anticipate that eHealth, Inc. will post -2.17 earnings per share for the current year.
eHealth Company Profile
(
Free Report)
eHealth, Inc operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services.
Featured Stories
Before you consider eHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eHealth wasn't on the list.
While eHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
